NGeneBio was founded in October 2015, develops in vitro diagnostics (IVD) / companion diagnostics (CDx) products and bioinformatics software with cutting-of-edge technologies including next-generation sequencing (NGS). We launched NGS-based oncology kits (BRCA/HEME/SOLID) & clinical NGS data analysis software (NGeneAnalySys) and NGenePlex™ nCoV qRT-PCR Kit against COVID-19 pandemic.